About this trial
The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.
Eligibility criteria
Qualifiers
Ages 18-70 years (inclusive)
Male or female
All genders, races, ethnic groups
MD-confirmed diagnosis of IC/BPS or CP/CPPS by study urologist or urogynecologist
Disqualifiers
Presence of a neurological condition (e.g., MS, Parkinson's disease, paraplegia) affecting the bladder
The presence of a symptomatic urethral stricture (males only)
History of cystitis caused by tuberculosis or radiation or chemotherapies
Participant has been diagnosed and treated for a pelvic-related malignancy (colon, bladder, prostate, ovarian, endometrial, uterine, testicular, penile, cervical, vaginal, or rectal cancer)
Trial design
Treatments tested in this trial
- Minimal Contact-Cognitive Behavior Therapy
- Patient Education/Support
Treatment groups
Sponsors and collaborators
State University of New York at Buffalo
Lead sponsor
University of California, Los Angeles
Collaborator
University of Michigan
Collaborator